ALC Stock Overview
Alcidion Group Limited, together with its subsidiaries, engages in the development and licensing of healthcare software products in Australia, New Zealand, and the United Kingdom.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Alcidion Group Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.045 |
| 52 Week High | AU$0.13 |
| 52 Week Low | AU$0.04 |
| Beta | 1.31 |
| 1 Month Change | -11.76% |
| 3 Month Change | -27.42% |
| 1 Year Change | -60.87% |
| 3 Year Change | -87.67% |
| 5 Year Change | -46.43% |
| Change since IPO | -30.77% |
Recent News & Updates
Recent updates
Little Excitement Around Alcidion Group Limited's (ASX:ALC) Revenues As Shares Take 29% Pounding
Jan 30
Shareholders Will Probably Hold Off On Increasing Alcidion Group Limited's (ASX:ALC) CEO Compensation For The Time Being
Nov 13Companies Like Alcidion Group (ASX:ALC) Can Afford To Invest In Growth
Oct 19We're Interested To See How Alcidion Group (ASX:ALC) Uses Its Cash Hoard To Grow
Jul 17Is There An Opportunity With Alcidion Group Limited's (ASX:ALC) 45% Undervaluation?
Jun 02Alcidion Group Limited (ASX:ALC) Just Reported And Analysts Have Been Cutting Their Estimates
Feb 25When Should You Buy Alcidion Group Limited (ASX:ALC)?
Nov 02When Will Alcidion Group Limited (ASX:ALC) Breakeven?
Apr 15Calculating The Fair Value Of Alcidion Group Limited (ASX:ALC)
Mar 28Shareholder Returns
| ALC | AU Healthcare Services | AU Market | |
|---|---|---|---|
| 7D | 0% | -5.1% | -2.2% |
| 1Y | -60.9% | 52.0% | 4.5% |
Return vs Industry: ALC underperformed the Australian Healthcare Services industry which returned 52% over the past year.
Return vs Market: ALC underperformed the Australian Market which returned 4.5% over the past year.
Price Volatility
| ALC volatility | |
|---|---|
| ALC Average Weekly Movement | 9.3% |
| Healthcare Services Industry Average Movement | 8.2% |
| Market Average Movement | 9.0% |
| 10% most volatile stocks in AU Market | 17.6% |
| 10% least volatile stocks in AU Market | 3.4% |
Stable Share Price: ALC's share price has been volatile over the past 3 months.
Volatility Over Time: ALC's weekly volatility (9%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2000 | 191 | Kate Quirke | www.alcidion.com |
Alcidion Group Limited, together with its subsidiaries, engages in the development and licensing of healthcare software products in Australia, New Zealand, and the United Kingdom. The company offers Miya Precision, a consolidated fast healthcare interoperability resource (FHIR) based platform to deliver smart healthcare; Smartpage, a smartphone and web-based system for hospital communication and task management to address the requirements of clinical and non-clinical users; Patientrack, a real-time patient monitoring and risk screening solution; Silverlink, a patient administration system; and ExtraMed, a clinical and patient flow management software. It also provides product implementation, product support and maintenance, systems integration, and data analysis services.
Alcidion Group Limited Fundamentals Summary
| ALC fundamental statistics | |
|---|---|
| Market cap | AU$63.10m |
| Earnings (TTM) | -AU$5.11m |
| Revenue (TTM) | AU$40.48m |
1.5x
P/S Ratio-11.8x
P/E RatioIs ALC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ALC income statement (TTM) | |
|---|---|
| Revenue | AU$40.48m |
| Cost of Revenue | AU$5.30m |
| Gross Profit | AU$35.17m |
| Other Expenses | AU$40.28m |
| Earnings | -AU$5.11m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.0038 |
| Gross Margin | 86.90% |
| Net Profit Margin | -12.63% |
| Debt/Equity Ratio | 0% |
How did ALC perform over the long term?
See historical performance and comparison